Public Health

Justice Department details Operation SpecTor results

Justice Department officials have detailed the results of Operation SpecTor - described by authorities as a globally coordinated effort spanning…

1 year ago

Center for Health Security recommends adequately funded, authorized and targeted CDC in response to Congressional reformation queries

Following up on a request for information (RFI) from U.S. Rep. Marionette Miller-Meeks (R-IA), in which she pushed for changes…

1 year ago

Bicameral TRANQ Research Act introduced to promote research, testing and more for Xylazine

Worried about the growing illicit use of the animal tranquilizer Xylazine, also known as Tranq, a group of senators and…

1 year ago

Bill seeks to stop fentanyl trafficking across U.S. border

U.S. Sens. Todd Young (R-IN), Bill Hagerty (R-TN), and eight colleagues are espousing the benefits of reintroducing the Stop Fentanyl…

1 year ago

DEA to host 24th National Drug Take Back Day

The Drug Enforcement Administration (DEA) is espousing the benefits of its 24th National Prescription Drug Take Back Day on April…

1 year ago

HHS releases new online educational platform, publication and report to aid cybersecurity in health sector

Due to the rising threat of cyberattacks against the health and public health sector, the U.S. Department of Health and…

1 year ago

Expanding fentanyl crackdown, Biden administration designates xylazine combos emerging threat

Xylazine, a non-opioid tranquilizer approved for veterinary use, was recently declared an emerging threat to the United States by Dr.…

1 year ago

Capitol Hill lawmakers vow to end U.S. drug shortages, dependency on Chinese pharma

The rising dependence that the United States has on many Chinese pharmaceuticals is worsening the nation’s drug shortage and creating…

1 year ago

Legislation targets emergency room care gap

U.S. Reps. Michael C. Burgess (R-TX) and Kathy Castor (D-FL) recently reintroduced the MISSION Zero Act, which would aid in…

1 year ago

Bipartisan legislation seeks to classify illicit xylazine use under Schedule III of the Controlled Substances Act

A bipartisan group of lawmakers recently introduced the Combating Illicit Xylazine Act, which seeks to classify the drug under Schedule…

1 year ago

This website uses cookies.